Compound 936
Identifiers
- Canonical SMILES: 
CCCCC1(CCN(CC1)c1ccc(cc1)C(=O)NS(=O)(=O)c1ccc(N[C@H](CCN(C)C)CSc2ccccc2)c(c1)N(=O)=O)OC
 - IUPAC name: 
4-(4-butyl-4-methoxypiperidin-1-yl)-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide
 - InChi: 
InChI=1S/C35H47N5O6S2/c1-5-6-19-35(46-4)20-23-39(24-21-35)29-14-12-27(13-15-29)34(41)37-48(44,45)31-16-17-32(33(25-31)40(42)43)36-28(18-22-38(2)3)26-47-30-10-8-7-9-11-30/h7-17,25,28,36H,5-6,18-24,26H2,1-4H3,(H,37,41)/t28-/m1/s1
 - InChiKey: 
PKTRSCZRZRTGKO-MUUNZHRXSA-N
 
External links
        
        ![]() 24776216  | 
      
External search
         
       | 
      
         
       | 
      
           
       | 
      
           
       | 
      
           
       | 
    
Bibliography (1)
Pharmacological data
| Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests | 
|---|---|---|---|
| 2 | 0 | 0 | 0 | 
Targets
| PPI family | Best activity | Diseases | MMoA | 
|---|---|---|---|
| BCL2-Like / BAX | 8.89 | cancer | Inhibition | 
Physicochemical filters
| Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
|---|---|---|---|---|
| Compliance | ||||
| MW | 697.30 g/mol | |||
| HBA | 11 | |||
| HBD | 2 | |||
| HBA + HBD | 13 | |||
| AlogP | 5.21 | |||
| TPSA | 136.80 | |||
| RB | 16 | 
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
| Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests | 
|---|---|---|---|---|
| 1 | 2 | 0 | 0 | 0 | 
Pharmacological data
| Bibliography | Name | Target | Competition | Assay type | Assay name | Cell line | Activity type | Activity | 
|---|---|---|---|---|---|---|---|---|
| 17256834 | 8c | BCL2  P10415  | 
                      | 
                    Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 7.70 | |
| 17256834 | 8c | B2CL1  Q07817  | 
                      | 
                    Biochemical assay | Fluorescence Polarization | pKi (inhibition constant, -log10) | 8.89 | 
| Ta | Structure | Name | Drugbank ID | 
|---|---|---|---|
| 0.5310 | Navitoclax | DB12340 | |
| 0.4621 | Venetoclax | DB11581 | |
| 0.4481 | [4-(4-PHENYL-PIPERIDIN-1-YL)-BENZENESULFONYLAMINO]-ACETIC ACID | DB07986 | |
| 0.4451 | Sulfabenzamide | DB09355 | |
| 0.4308 | Pipotiazine | DB01621 | |
| 0.4180 | 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide | DB04394 | |
| 0.4167 | 3-(1h-Indol-3-Yl)-2-[4-(4-Phenyl-Piperidin-1-Yl)-Benzenesulfonylamino]-Propionic Acid | DB02449 | |
| 0.4050 | Zafirlukast | DB00549 | |
| 0.4022 | Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Octyl-Amide | DB03031 | |
| 0.4010 | 5-[4-(1-Carboxymethyl-2-Oxo-Propylcarbamoyl)-Benzylsulfamoyl]-2-Hydroxy-Benzoic Acid | DB03124 | |
| 0.3991 | Nelfinavir | DB00220 | |
| 0.3956 | Adamantane-1-Carboxylic Acid-5-Dimethylamino-Naphthalene-1-Sulfonylamino-Butyl-Amide | DB04032 | |
| 0.3947 | Repinotan | DB06506 | |
| 0.3918 | Saccharin | DB12418 | |
| 0.3871 | VX-659 | DB15177 | 




